About Coagulo
Coagulo is a company based in Newton (United States) founded in 2018.. Coagulo has raised $6.5 million across 3 funding rounds from investors including Good Growth Capital, 20/20 HealthCare Partners and Sands Capital. Coagulo offers products and services including Precision-Medicine Platform and Coagulation Management System. Coagulo operates in a competitive market with competitors including BioSerenity, QuidelOrtho, NuvoAir, MedTel Healthcare and ProciseDx, among others.
- Headquarter Newton, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Coagulo Medical Technologies Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$6.5 M (USD)
in 3 rounds
-
Latest Funding Round
-
Investors
Good Growth Capital
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Coagulo
Coagulo offers a comprehensive portfolio of products and services, including Precision-Medicine Platform and Coagulation Management System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for analyzing clotting cascade abnormalities in medical research.
System for investigational use in detecting blood disorders.
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Coagulo
Coagulo has successfully raised a total of $6.5M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Last Round
-
First Round
First Round
(01 Sep 2020)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2020 | Amount | Grant - Coagulo | Valuation |
investors |
|
| Dec, 2020 | Amount | Series A - Coagulo | Valuation | 20/20 HealthCare Partners | |
| Sep, 2020 | Amount | Grant - Coagulo | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Coagulo
Coagulo has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Good Growth Capital, 20/20 HealthCare Partners and Sands Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are made in healthcare technology and life sciences.
|
Founded Year | Domain | Location | |
|
Early-stage investments are made in life sciences and technologies.
|
Founded Year | Domain | Location | |
|
Venture capital investments are provided by IAG Capital Partners.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Coagulo
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Coagulo
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Coagulo Comparisons
Competitors of Coagulo
Coagulo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioSerenity, QuidelOrtho, NuvoAir, MedTel Healthcare and ProciseDx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of smart healthcare solutions for sleep and EEG lab management
|
|
| domain | founded_year | HQ Location |
Provider of healthcare information services
|
|
| domain | founded_year | HQ Location |
Clinical decision support tools for respiratory diseases are provided.
|
|
| domain | founded_year | HQ Location |
Remote patient monitoring software is developed for healthcare providers.
|
|
| domain | founded_year | HQ Location |
Point-of-care diagnostic devices for immunoassay tests are provided to clinicians.
|
|
| domain | founded_year | HQ Location |
ICT-based products and solutions are developed for healthcare.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Coagulo
Frequently Asked Questions about Coagulo
When was Coagulo founded?
Coagulo was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Where is Coagulo located?
Coagulo is headquartered in Newton, United States. It is registered at Newton, Massachusetts, United States.
Who is the current CEO of Coagulo?
Jarrod Niebloom is the current CEO of Coagulo.
Is Coagulo a funded company?
Coagulo is a funded company, having raised a total of $6.5M across 3 funding rounds to date. The company's 1st funding round was a Grant of $253.21K, raised on Sep 01, 2020.
What does Coagulo do?
Coagulo provides a precision-medicine platform for the diagnosis of blood coagulation disease. They provide microfluidic technology and proprietary data analytics and digital connectivity. The companys new point-of-care testing platform delivers accessible and personalized diagnosis and management of all coagulation-related diseases. The platform detects, identifies, and quantifies the effect of all anticoagulants in whole blood and communicates actionable results to healthcare providers. The software has features like the portable and automated reader, trend monitoring and treatment optimization, and personalized diagnosis and management.
Who are the top competitors of Coagulo?
Coagulo's top competitors include MedTel Healthcare, QuidelOrtho and Neurosynaptic.
What products or services does Coagulo offer?
Coagulo offers Precision-Medicine Platform and Coagulation Management System.
Who are Coagulo's investors?
Coagulo has 6 investors. Key investors include Good Growth Capital, 20/20 HealthCare Partners, Sands Capital, IAG Capital Partners, and America’s Seed Fund.